Perio Therapia
Latest round
- Series D
Last raised
- Jun 2026
Total raised
- $12M
Investors
- 5
About Perio Therapia
a. Perio Therapia, is engaged in developing pathological periostin-targeting antibody therapeutics, related diagnostic technologies, and drug discovery research for conditions including cancer and inflammatory diseases.a. Perio Therapia, focuses on therapeutics for challenging diseases and was founded in 2017 in Suita-shi, Japan. The company's CEO is TOCHIHARA Yosuke. Perio Therapia specializes in developing innovative therapeutics for hard-to-treat diseases, particularly with drug candidates targeting pathological periostin. Their primary offerings include neutralizing antibodies aimed at treating triple-negative breast cancer (TNBC) and other metastatic HER2-negative breast cancers. The company serves research institutions and healthcare providers primarily in Japan, while also preparing to enter international markets. Collaborations with prominent academic institutions like Osaka University enhance their product development, ensuring alignment with the latest scientific advancements. Perio Therapia generates revenue through partnerships and collaborations with academic institutions and pharmaceutical companies, focusing on the development and commercialization of their proprietary therapies. Specifically, their neutralizing antibodies targeting pathological periostin are anticipated to attract significant interest in both clinical and commercial spheres after reaching advanced stages of development.
Who invested in Perio Therapia
5 investors across 5 rounds
See all investors in Perio Therapia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Perio Therapia
Who invested in Perio Therapia?
Perio Therapia has 5 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Perio Therapia raised?
Perio Therapia has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Perio Therapia last raise money?
Perio Therapia's most recent round on record is a Series D, in Jun 2026.
What does Perio Therapia do?
Perio Therapia is a biotechnology company.
Where is Perio Therapia headquartered?
Perio Therapia is headquartered in Osaka, Japan.
Which VCs invest in companies like Perio Therapia?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Perio Therapia's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Perio Therapia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.